v3.7.0.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2017
May 01, 2017
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q1  
Entity Registrant Name Protalix BioTherapeutics, Inc.  
Entity Central Index Key 0001006281  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Trading Symbol PLX  
Entity Common Stock, Shares Outstanding   126,499,455